Sophiris Bio Inc. (SPHS) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:SPHS

0.23
-0.35 (-60.3%)
At close: Mar 11, 2020
0.2
-0.03 (-13.04%)
After Hours: 3/11/2020, 10:34:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

SPHS Key Statistics, Chart & Performance

Key Statistics
Market Cap8.18M
Revenue(TTM)N/A
Net Income(TTM)37.00K
Shares35.55M
Float32.33M
52 Week High1.17
52 Week Low0.23
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.33
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
SPHS short term performance overview.The bars show the price performance of SPHS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

SPHS long term performance overview.The bars show the price performance of SPHS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of SPHS is 0.23 null. In the past month the price decreased by -65.86%. In the past year, price decreased by -78.5%.

Sophiris Bio Inc. / SPHS Daily stock chart

SPHS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
SPHS Full Technical Analysis Report

SPHS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SPHS. Both the profitability and financial health of SPHS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SPHS Full Fundamental Analysis Report

SPHS Financial Highlights

Over the last trailing twelve months SPHS reported a non-GAAP Earnings per Share(EPS) of -0.33000000000000007. The EPS increased by 31.25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 0.52%
ROE N/A
Debt/Equity -1.12
Chartmill High Growth Momentum
EPS Q2Q%36.36%
Sales Q2Q%N/A
EPS 1Y (TTM)31.25%
Revenue 1Y (TTM)N/A
SPHS financials

SPHS Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y34.62%
Revenue Next YearN/A
SPHS Analyst EstimatesSPHS Analyst Ratings

SPHS Ownership

Ownership
Inst Owners0%
Ins Owners0.56%
Short Float %N/A
Short RatioN/A
SPHS Ownership

About SPHS

Company Profile

Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.

Company Info

Sophiris Bio Inc.

1258 PROSPECT STREET

LA JOLLA CA 92037

CEO: Randall E. Woods

Phone: 858-777-1760

Sophiris Bio Inc. / SPHS FAQ

What does SPHS do?

Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.


Can you provide the latest stock price for Sophiris Bio Inc.?

The current stock price of SPHS is 0.23 null. The price decreased by -60.3% in the last trading session.


What is the dividend status of Sophiris Bio Inc.?

SPHS does not pay a dividend.


What is the ChartMill technical and fundamental rating of SPHS stock?

SPHS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is Sophiris Bio Inc. (SPHS) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SPHS.


What is Sophiris Bio Inc. worth?

Sophiris Bio Inc. (SPHS) has a market capitalization of 8.18M null. This makes SPHS a Nano Cap stock.